As at Jan 14, 2025, the TMDX stock has a PE ratio of 63.17. This is based on the current EPS of $0.99 and the stock price of $62.54 per share.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
TMDX TransMedics Group Inc | 64.49 | $2.14B |
OBIO Orchestra BioMed Holdings Inc | N/A | $202.23M |
OM Outset Medical Inc | N/A | $42.7M |
As of Jan 14, 2025, TMDX stock has a price to earnings ratio of 63.17.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jan 14, 2025), TransMedics Group's stock price is $62.54. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.99. Therefore, TransMedics Group's P/E ratio for today is 63.17. PE RATIO(63.17) = STOCK PRICE($62.54) / TTM EPS($0.99)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.